Team van Professoren Sotiriou Christos |
|
|
|
Titel van het project:
Circulating Tumor Cells: Prognostic and Predictive Tools in HER2-Positive Early Breast Cancer Patients Treated with Anti-HER2 Targeted Agents: The ALTTO Trial
JULES BORDET INSTITUTE Toegekend bedrag: € 200 000, verdeeld over 3 jaar
|












